The appointment of appointment and the report announcing the agenda can be viewed from the next page:

https://www.ansm.sante.fr/s-informer/points-d-information-points-d-information/lutenyl-luteran-et-risque-de-meningiome-programme-de-la-consultation-publique-du-2-novembre-2020-Point-information

Given the news of the last days, the course of this consultation time and the terms of its dissemination on the Internet have evolved. We decided, in connection with you, that the hearings by the Committee will take place on Monday, and that the members of the Committee will meet in a second step in order to establish the appropriate measures to use Lotényl /Lotéran, with regard to the risk of meningioma and the needs of women. The date of this next meeting will be communicated later.

Par ailleurs, le format initialement prévu a aussi été aménagé : la consultation publique ne sera pas diffusée en direct et sera disponible prochainement sur la chaine YouTube de l’ANSM.

Find our other articles here